Zelira Therapeutics Limited

A$0.50As of Sun 8 Nov 2026, 12:00 UTC
ASX:ZLDHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (21.33%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.63
PE TTM —
TSR TTM 42.86%
Mkt cap A$5.949M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.55
9.93%
49.18%
Hold 6|8|5|4|10
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.01
0.01
0.01
0.01
18.27%
4.06%
5.20%
21.43%
Revenue$M
0.287
0.295
0.291
0.297
6.84%
10.43%
8.13%
6.78%
Peers (US$4.086M)
Cap (US$)
PE
3.826M
—
3.645M
—
Capital
TTM
5Y
10Y
Leveragex
5.245
0.770
0.634
EBIT/Intx
0.613
0.167
0.192
Own earn%
22.02
(139.78)
(127.14)
Sh yield%
37.34
6.21
11.60
Owners
Insiders/Inst%
4.15
39.45
Short interest%
0.64
SBC / revenue%
2.46
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
8–23
$1 testx
—
Incr. ROIC%
1